Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025
Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis".
Journal: Clinical lung cancer
Published: November 14, 2025
Solid phase extraction and high-performance liquid chromatographic determination of lazertinib in human plasma.
Journal: Drug discoveries & therapeutics
Published: October 19, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
Journal: The New England journal of medicine
Published: September 09, 2025
Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis.
Journal: Clinical lung cancer
Published: September 09, 2025
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
Journal: BMJ (Clinical research ed.)
Published: September 02, 2025
Who Truly Benefits From First-Line Intensification in EGFR-Mutant NSCLC?
Journal: Current oncology reports
Published: August 08, 2025
Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: July 25, 2025
A Response to the Letter to the Editor Regarding "Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 22, 2025
Comprehensive management strategies for amivantamab-induced toxicities and review of the literature.
Comprehensive management strategies for amivantamab-induced toxicities and review of the literature.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 15, 2025
Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.
Journal: Clinical drug investigation
Published: June 27, 2025
Last Updated: 01/07/2026